Medical Device Testing Services Market (By Service: Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing [Bio-Burden Determination, Pyrogen and Endotoxin Testing, Sterility Test and Validation, Anti-microbial Activity Testing, Other Services], Package Validation; By Phase: Preclinical [Antimicrobial Wound Dressings, Medical Coatings, Others], Clinical) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

The global medical device testing service market size is anticipated to reach around USD 14.2 bn by 2026, growing with 12.2% of CAGR during the forecast time period 2018 to 2026.

The medical device testing service market is driven by growing spending in preclinical phase of medical devices.

Market Dynamics

Rise of drug device combination, personalized medication, artificial intelligence (AI), wearables and focus on real-time patient monitoring resulted in complex medical devices ecosystem. To match these factors, gadgets now have to undergo shear testing in augmented conditions to obtain marketing approval. Conducting these tests in-house needs a lot of time, cost, and labour; this is anticipated to increase the need for outsourcing of these services thereby increasing the market development.

Market Insights

Growing need for in-vitro tests is also anticipated to boost the industry, as a lot of CROs are emerging novel methods to replace the traditional in-vivo tests that require animal testing. Development in the growth and standardization of novel in vitro test approaches; particularly for sensitization, cytotoxicity, and irritation that are the basic test required for all the medical device is also expected to support industry development.

Market Segmentation

Market By Service

  • Biocompatibility Tests
  • Chemistry Test
  • Microbiology & Sterility Testing
    • Bio-Burden Determination
    • Pyrogen and Endotoxin Testing
    • Sterility Test and Validation
    • Anti-microbial Activity Testing
    • Other Services
  • Package Validation

Market By Phase

  • Preclinical
    • Antimicrobial Wound Dressings
    • Medical Coatings
    • Others
  • Clinical

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

Asia Pacific captures the largest market share in the medical device testing services market due to augmented outsourcing in nations, for instance, as India and China. Contract Research Organizations (CROs) are spending heavily in emerging nations of APAC due to lower cost and easy accessibility of trained labour. North America captures the second-largest share in 2018 and is anticipated to observer important development during the forecast timeframe.

This development can be credited to the fact that it is one of the top industrial hubs of complex, high-end, and reliable medical gadgets. Many CROs have a developed business in the region that delivers complete range of testing services for businesses. The Europe region is led by nations (Germany Spain, U.K., France, and Italy) EU5. Increasing demand for cost cutting and growing difficulty in product designing are anticipated to be the major industry drivers.

Market Participants

Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. The major players associated with the medical device testing servicesmarket are Medical Device Testing Services, Toxikon, Inc., American Preclinical Services LLC, SGS SA, Charles River Laboratories International, Inc., Eurofins Scientific, LLC, Sterigenics International LLC, Intertek Group PLC, North American Science Associates, Inc., WuXiAppTec Group, and Pace Analytical Services, LLC.


Frequently Asked Questions

The medical device testing service market is driven by growing spending in preclinical phase of medical devices.

According to Acumen Research and Consulting, the medical device testing service market value is expected to be worth around USD 14.2 bn by 2026.

The medical device testing service market is anticipated to grow over 12.2% CAGR during the forecast period 2019 to 2026.

Asia Pacific captures the largest market share in the medical device testing services market due to augmented outsourcing in nations, for instance, as India and China.

The major players operating in the medical device testing services market are Medical Device Testing Services, Toxikon, Inc., American Preclinical Services LLC, SGS SA, Charles River Laboratories International, Inc., Eurofins Scientific, LLC, Sterigenics International LLC, and Intertek Group PLC.

The medical device testing service market is segmented into North America, Europe, Asia Pacific, Latin America and The Middle East & Africa (LAMEA).

Europe is projected to grow at a fast pace during forecast period in the medical device testing service market.

Cart Summary


60